Odyssey Therapeutics, Inc. (ODTX) vs Pacific Biosciences of California, Inc. (PACB)
A side-by-side comparison of Odyssey Therapeutics, Inc. and Pacific Biosciences of California, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ODTX
Odyssey Therapeutics, Inc.
$18.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PACB
Pacific Biosciences of California, Inc.
$2.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ODTX vs PACB
growth of $100 · dividends reinvested · last 1yODTX +26.9% (+26.9%/yr)PACB +103.5% (+103.5%/yr)PACB compounded faster over this window
ODTX PACB
ODTX vs PACB: by the numbers
- •ODTX is the larger company ($871M vs $839M market cap).
- •Both run net losses; PACB's is the smaller (-82.49% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | ODTX | PACB |
|---|---|---|
| P/S ratio | N/A | 5.27 |
| P/B ratio | 2.07 | N/A |
Profitability
| Metric | ODTX | PACB |
|---|---|---|
| Gross margin | 100.00% | 35.97% |
| Operating margin | -5415.19% | -348.46% |
| Net margin | -4994.86% | -82.49% |
| ROIC | -66.23% | -23.80% |
Growth (annualized)
| Metric | ODTX | PACB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.52% |
| Total return CAGR (5Y) | N/A | -35.20% |
Go deeper
Dig into the metrics
Odyssey Therapeutics ROEPacific Biosciences of California ROEOdyssey Therapeutics operating marginPacific Biosciences of California operating marginOdyssey Therapeutics revenue growthPacific Biosciences of California revenue growthOdyssey Therapeutics free cash flowPacific Biosciences of California free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.